For professionals in the chemical and pharmaceutical sectors, the consistent and reliable supply of specialized intermediates is non-negotiable. (R)-3-Amino-4-(4-chlorophenyl)butyric Acid Hydrochloride (CAS 331763-59-8) is one such critical compound, valued for its unique properties and applications in advanced synthesis and research. Typically presented as an off-white to white solid or powder with a purity around 97%, this chemical intermediate is essential for many R&D projects.

The primary driver for demand for this compound is its potential as a GABA receptor agonist. This makes it invaluable for researchers investigating neurological conditions, particularly those related to muscle spasticity. Pharmaceutical companies often seek to buy this chemical to use in their drug discovery pipelines, aiming to develop new therapeutic interventions. Understanding the compound’s molecular formula (C10H13Cl2NO2) and molecular weight (250.12 g/mol) is fundamental for effective use in synthesis.

When considering where to buy (R)-3-Amino-4-(4-chlorophenyl)butyric Acid Hydrochloride, buyers often look towards manufacturers and suppliers in China, renowned for their extensive chemical production capabilities. The benefits of sourcing from this region include competitive pricing, especially for bulk orders, and a generally robust supply chain. A key aspect for buyers is identifying a supplier that not only offers good prices but also guarantees consistent quality and timely delivery.

For R&D departments, the ability to buy smaller quantities for initial studies is as important as securing larger amounts for scaled-up manufacturing. Therefore, engaging with suppliers who can accommodate varying order sizes is crucial. Procurement managers should always request detailed product specifications, Certificates of Analysis (CoA), and Material Safety Data Sheets (MSDS) to ensure compliance and quality assurance.

Building a strong relationship with a reliable manufacturer for essential intermediates like (R)-3-Amino-4-(4-chlorophenyl)butyric Acid Hydrochloride is a strategic move for any company involved in pharmaceutical development. It ensures that critical research and production timelines are met, and the integrity of the final product is maintained.